What the buyer needs
AI summaryThe Department of Veterans Affairs Network Contracting Office 23 seeks market research responses from capable businesses to supply FDG (Fluorodeoxyglucose F18) radiopharmaceutical agents to the Minneapolis VA Health Care System. The required scope includes dispensing, quality control testing, packaging, and courier delivery of radiopharmaceuticals that comply with Nuclear Regulatory Commission, OSHA, and USP 797 standards. Interested vendors must submit responses via email to [email protected] no later than November 11, 2026, at 5:00 PM Central Time. Submissions must include the vendor's Unique Entity Identifier number, proof of capability, competitive pricing details, and responses to seven market research questions addressing socio-economic category, manufacturing capability or authorized distribution, country of origin, existing government contracts, subcontracting plans, and delivery lead times.
Scope of work
- Provide brand name or equal FDG (Fluorodeoxyglucose F18) radiopharmaceutical agents, estimated quantity 1600
- Delivery of radiopharmaceutical agents directly to specified hot rooms at Minneapolis VA Health Care System
- On demand, as needed order fulfillment between 8:00 am and 3:00 pm Monday through Friday
- Perform and document quality control on each dispensed radiopharmaceutical agent
- Package and transport materials in compliance with NRC, DOT, and OSHA regulations
- Maintain delivery logs, delivery tickets, and sales slips for all shipments
- Provide Material Safety Data Sheets (MSDS) and package inserts in binders or via website
- Replace damaged, incorrect, or unsatisfactory items within 48 hours of notification at no cost
Minimum qualifications
- Must be licensed by the State of Minnesota
- Must be licensed by the Nuclear Regulatory Commission
- Must be regularly established in the business of providing radiopharmaceuticals
- Must follow all USP 797 guidelines
- Couriers/drivers must maintain Motor Carrier Permit, hazardous material license, and valid state-issued drivers licenses
- Delivery personnel must be able to read, write, speak, and understand English
Documents to include with your response
- Organization Unique Entity Identifier number
- Description of proof of capability
- Answers to sources sought questions 1 through 7
- Letter showing organization is an authorized distributor if not the manufacturer
- Certificate under FAR Provision 52.225-2(b) identifying item and country of origin
- Copies of State of Minnesota and Nuclear Regulatory Commission licenses and certifications upon request
- Copy of laboratory current quality control manual
- Verification of USP 797 compliance upon request
How to submit
- Method
- Instructions
- Send information to [email protected] on or before November 11th, 2026. Only emailed responses will be considered.
Incumbent and award research
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Pharmaceutical Preparation Manufacturing). This is not this requirement's award history.
Recent similar awards: Department of Veterans Affairs, NAICS 325412, performed in MN
| Vendor and award | Value | Ends |
|---|---|---|
| EXELAN PHARMACEUTICALS INC36C26326F0015 · LENALIDOMIDE MEDICATION FOR THE ST. CLOUD VA HEALTH CARE SYSTEM | $550.0K | Sep 30, 2026 |
| BOSTON SCIENTIFIC CORP36C25224N0281 · THERASPHERE LIVER CANCER MEDICINE | $287.7K | May 31, 2025 |
| INSTYMEDS CORP36C25720P1106 · DISPENSING STATIONS | $439.9K | Dec 31, 2024 |
| HENNEPIN HEALTHCARE SYSTEM INC36C26324P0060 · ARTESUNATE MEDICATION FOR MINNEAPOLIS VAMC | $30,478 | Oct 5, 2023 |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC36C26323N0017 · DO 10/1/2022 THROUGH 09/30/2023 | $158.3K | Sep 30, 2023 |
Top vendors in this category: Department of Veterans Affairs, NAICS 325412, since Oct 1, 2024
4,164 contract awards in this NAICS over the period.
- 1. MCKESSON CORPORATION$26.1B
- 2. EXELAN PHARMACEUTICALS INC$100.2M
- 3. PROGENICS PHARMACEUTICALS INC$84.1M
- 4. CARDINAL HEALTH 414, LLC$61.7M
- 5. NOVARTIS PHARMACEUTICALS CORPORATION$55.3M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.